Risk stratification schemes, anticoagulation use and outcomes: the risk–treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation
Roopinder K. Sandhu(Western University), Finlay A. McAlister(University of Alberta)
Cited by 79
Related Papers
Screening for Atrial Fibrillation
|Circulation|2017|535
Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation
|JAMA Cardiology|2016|213
The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults
|JAMA Internal Medicine|2022|142
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
|PLoS Medicine|2019|125
Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation
|JACC Heart Failure|2017|95